Why did MSB rise 23.4% on 29 Oct 2026?

MSB

Mesoblast · Pharmaceuticals, Biotechnology & Life Sciences

▲ 23.4%at the close on Thu 29 Oct

$10,000 in MSB shares rose to $12,340 that day. It was up as much as 26.6% during the day: about 10 times a usual day's move for MSB, with twice the usual shares traded.

A company update

Mesoblast released a market-sensitive quarterly activities and cash flow report that appears to have contained positive news, driving the stock up over 20%.

$10,000 in ISO, the ETF that holds the most MSB, gained ▲ $18 that day. In IOZ it was a gain of $2. 17 ETFs hold MSB ›

An ETF is one investment, bought on the stock exchange, that holds many companies at once.

The news

We found no news articles for this move. Headlines link to the publisher.

How the model got there ›

The only stock-specific catalyst is the market-sensitive Quarterly Activities/Appendix 4C Cash Flow Report released at 22:54 UTC on 28 October, approximately 3 hours before detection — timing and sensitivity flag align well with the price move. No other Layer 2 signals are proportionate: the same-industry peers' median move was just 2.06% and the ASX Healthcare sector index (^AXHJ) moved only 0.70%, both far below the 20.21% move, ruling out sector_flow. The ASX 200 moved only 0.29%, ruling out macro/market-wide explanations. The announcement is categorised as a quarterly activities report (not a formal earnings result), so operational_update is the best-fit taxonomy category, though positive cash flow or clinical/business progress within the report is the probable catalyst; confidence is medium rather than high because the full content of the report is not available to confirm the specific positive element.

Company announcements

  • Quarterly Activities/Appendix 4C Cash Flow Report

    Commitments Test Entity - First Quarter Activity Report · 29 Oct 2026 · market sensitive

All announcements on asx.com.au ↗

Markets that moved with it · 4

Markets that tend to move with this stock, on the same day or the day before.

  • S&P 500A market it earns in · the day beforesame direction+0.28%
  • Nikkei 225A market it earns in · the day beforesame direction+1.08%
  • ASX 200 Health CareIts sector · same daysame direction+0.70%
  • US dollar / Chinese yuanA market it earns in · the day beforeother way−0.16%

What $10,000 in each ETF gained that day

$77 of every $10,000 in ISO was Mesoblast; it rose 23.4%, so $10,000 in ISO gained $18.

9 more ETFs ›

How is the site working for you?